Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | CTSS | P25774 | 6/20 | 0.60 |
| ▸ | CTSL | P07711 | 5/20 | 0.60 |
| ▸ | CTSK | P43235 | 6/20 | 0.59 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.59 |
| ▸ | ELANE | P08246 | 1/20 | 0.58 |
| ▸ | TACR1 | P25103 | 1/20 | 0.56 |
| ▸ | CTSB | P07858 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8041576 | 0.88 | ATM (0.64) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL308291 | 0.88 | ATM (0.64) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL15691156 | 0.87 | CTSS (0.61) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL7269610 | 0.87 | CTSS (0.61) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL6841165 | 0.87 | CTSS (0.61) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL11094221 | 0.86 | ATM (0.62) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL22808751 | 0.86 | ATM (0.62) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL19062411 | 0.86 | CTRB1 (0.62) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL6140023 | 0.85 | ATM (0.61) | ATMCTSSCTSLCTSKCTRB1 | |
| SCHEMBL17688547 | 0.85 | ATM (0.61) | ATMCTSSCTSLCTSKCTRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-58049395-A | — | — | None | — | — | JP | disclosed |
| JP-61246196-A | — | — | None | — | — | JP | disclosed |
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-3450450-B1 | VANCOMYCIN DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2025-08-27 | — | — | EP | disclosed |
| CN-115175735-B | Antiviral compounds | 吉利德科学公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20230295201-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230099027-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2023-03-30 | — | — | US | disclosed |
| EP-4125935-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2023-02-08 | — | — | EP | disclosed |
| EP-4106877-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-12-28 | — | — | EP | disclosed |
| CN-115515604-A | Virucidal compositions and uses thereof | 洛桑联邦理工学院 | 2022-12-23 | — | — | CN | disclosed |
| EP-0707488-A1 | CYCLOHEXAPEPTIDYL AMINE COMPOUNDS | MERCK & CO. INC. (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0701561-A1 | DESOXYAZAPHOSPHOLIPID DERIVATIVES HAVING INHIBITING ACTIVITY ON PHOSPHOLIPASE A2 | LABORATORIOS MENARINI S.A. (ES) | 1996-03-20 | — | — | EP | disclosed |
| WO-1995032710-A1 | COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION | MERCK & CO., INC. (US) | 1995-12-07 | — | — | WO | disclosed |
| EP-0639586-A1 | Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them | ADIR ET COMPAGNIE (FR) | 1995-02-22 | — | — | EP | disclosed |
| WO-1994028004-A1 | DESOXYAZAPHOSPHOLIPID DERIVATIVES HAVING INHIBITING ACTIVITY ON PHOSPHOLIPASE A2 | LABORATORIOS MENARINI S.A. (ES) | 1994-12-08 | — | — | WO | disclosed |
| WO-1994025048-A1 | CYCLOHEXAPEPTIDYL AMINE COMPOUNDS | MERCK & CO., INC. (US) | 1994-11-10 | — | — | WO | disclosed |
| JP-S61246196-A | 5'-O-ACYL-5-FLUOROURIDINE AND PRODUCTION THEREOF | FUJI KAGAKU KOGYO KK | 1986-11-01 | — | — | JP | disclosed |
| JP-S5849395-A | NOVEL NITROSOUREA COMPOUND | SUAMI TETSUO | 1983-03-23 | — | — | JP | disclosed |
| US-4092324-A | ANTIARTERIOSCLEROSIS AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-05-30 | — | — | US | disclosed |
| US-4008265-A | ANTIARTERIOSCLEROSIS | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295201-A1 | ANTIVIRAL COMPOUNDS | MAVS, HAVCR2, ZC3HAV1 | ATM 4112/4885CTSS 1495/4885CTSL 760/4885 |
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | IRF3, IFNAR1, HAVCR2 | ATM 4118/4885CTSS 2261/4885CTSL 2167/4885 |
| US-20230099027-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | NEU3, NEU1, SIGLEC9 | ATM 2611/4885CTSS 384/4885CTSL 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.